Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

Antonia MS Mueller; Jonathan Hebb; Idit Sagiv-Barfi; Aurelien Marabelle; Roch Houot; Amanda Rajapaksa; Debra K Czerwinski; Serena Chang; Cariad Chester; Mohith Sadaram; Erin Waller; Ronald Levy; Holbrook Kohrt

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

【24h】

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

机译：顺序肿瘤和双重免疫靶向免疫疗法：利妥昔单抗抗4-14-1bb刺激和PD-1阻断的淋巴瘤活性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2014年第s3期|共页
作者
Antonia MS Mueller; Jonathan Hebb; Idit Sagiv-Barfi; Aurelien Marabelle; Roch Houot; Amanda Rajapaksa; Debra K Czerwinski; Serena Chang; Cariad Chester; Mohith Sadaram; Erin Waller; Ronald Levy; Holbrook Kohrt;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor [J] . Shindo Yoshitaro, Yoshimura Kiyoshi, Kuramasu Atsuo, Anticancer Research: International Journal of Cancer Research and Treatment . 2015,第1期

机译：4-1BB激活和PD-1阻断的联合免疫疗法增强了皮下肿瘤小鼠模型的抗肿瘤功效。
2. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors [J] . Rikke B. Holmgaard, Dmitriy Zamarin, Alexander Lesokhin, EBioMedicine . 2016,第2期

机译：用集落刺激因子-1受体阻滞靶向髓样来源的抑制细胞可以逆转表达吲哚胺2,3-双加氧酶的肿瘤对免疫疗法的免疫抵抗
3. Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy? [J] . Fei Tang, Pan Zheng Cell & Bioscience . 2018,第1期

机译：肿瘤细胞与宿主免疫细胞：谁的PD-L1有助于PD-1 / PD-L1阻断介导的癌症免疫治疗？
4. Synergistically Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Blockade of PD1 and IDO [C] . Yanqi Ye, Jinqiang Wang, Quanyin Hu, Society for Biomaterials annual meeting and exposition . 2017

机译：协同经皮免疫疗法可通过阻断PD1和IDO增强抗肿瘤免疫反应
5. T Cell Function and PD-1 Checkpoint Blockade in Tumor Progression [D] . Wang, Ziming. 2019

机译：T细胞功能和PD-1检查点延迟肿瘤进展
6. Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade [O] . Antonia MS Mueller, Jonathan Hebb, Idit Sagiv-Barfi, 2014

机译：顺序肿瘤和双重免疫靶向免疫疗法：利妥昔单抗的抗4-14-1bb刺激和PD-1阻断活性
7. Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade [O] . 2014

机译：顺序肿瘤和双重免疫靶向免疫疗法：利妥昔单抗的抗4-14-1bb刺激和PD-1阻断活性

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

著录项

相似文献

相关主题

期刊订阅